About Pharmaceutics International
Pharmaceutics International is a company based in Hunt Valley (United States) founded in 1994 was acquired by Jabil in February 2025.. Pharmaceutics International has raised $171.23 million across 12 funding rounds from investors including Jabil, PharmaScience and Signet Healthcare Partners. Pharmaceutics International offers products and services including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing. Pharmaceutics International operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Hunt Valley, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharmaceutics International, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Pharmaceutics International
Pharmaceutics International offers a comprehensive portfolio of products and services, including Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides reliable testing for drug quality and compliance.
Develops stable formulations for various pharmaceutical products.
Handles aseptic fill-finish for injectable drug manufacturing.
Produces tablets, capsules, and liquids for oral medications.
Unlock access to complete
Unlock access to complete
Funding Insights of Pharmaceutics International
Pharmaceutics International has successfully raised a total of $171.23M across 12 strategic funding rounds. The most recent funding activity was a Unspecified round of $11.25 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Unspecified — $11.2M
-
First Round
First Round
(14 Sep 2016)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Unspecified - Pharmaceutics International | Valuation |
investors |
|
| Jun, 2023 | Amount | Unspecified - Pharmaceutics International | Valuation |
investors |
|
| Dec, 2022 | Amount | Unspecified - Pharmaceutics International | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pharmaceutics International
Pharmaceutics International has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Jabil, PharmaScience and Signet Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location | |
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Hildred is focused on private equity investments in healthcare.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pharmaceutics International
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pharmaceutics International
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmaceutics International Comparisons
Competitors of Pharmaceutics International
Pharmaceutics International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| domain | founded_year | HQ Location |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| domain | founded_year | HQ Location |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| domain | founded_year | HQ Location |
APIs and finished products are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| domain | founded_year | HQ Location |
APIs and peptides are developed and manufactured by Asymchem.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmaceutics International
Frequently Asked Questions about Pharmaceutics International
When was Pharmaceutics International founded?
Pharmaceutics International was founded in 1994 and raised its 1st funding round 22 years after it was founded.
Where is Pharmaceutics International located?
Pharmaceutics International is headquartered in Hunt Valley, United States. It is registered at Hunt Valley, Maryland, United States.
Is Pharmaceutics International a funded company?
Pharmaceutics International is a funded company, having raised a total of $171.23M across 12 funding rounds to date. The company's 1st funding round was a Unspecified of $3M, raised on Sep 14, 2016.
What does Pharmaceutics International do?
Pharmaceutics International was founded in 1994 and is located in Hunt Valley, United States. Operations are conducted as a contract development and manufacturing organization (CDMO) within the pharmaceutical sector. Services are centered on the production of various dosage forms, including solids, liquids, and semi-solids. Support is provided to clients for formulation development, scale-up, and commercial manufacturing, with a focus on regulatory compliance and quality standards.
Who are the top competitors of Pharmaceutics International?
Pharmaceutics International's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
What products or services does Pharmaceutics International offer?
Pharmaceutics International offers Contract Analytical Services, Formulation Development Services, Aseptic Manufacturing, and Oral Manufacturing.
Who are Pharmaceutics International's investors?
Pharmaceutics International has 5 investors. Key investors include Jabil, PharmaScience, Signet Healthcare Partners, Athyrium Capital Management, and Hildred.